Methylation is one of the most fundamental biochemical processes in the body, essential for DNA repair, detoxification, neurotransmitter balance, and much more. When methylation pathways are disrupted—particularly through MTHFR and related gene mutations—the effects can be wide-ranging and profound.
Dr Ben Lynch is internationally recognised as a leader in the field of methylation and nutrigenomics. In this Masterclass, he presents the latest insights into how genetic polymorphisms impact health—and more importantly, how to work with them in clinical practice.
This series focuses on three of today’s most pressing clinical challenges: mental health, cardiovascular disease, and cancer. Dr Lynch guides you through the key mechanisms, how to identify relevant genetic variations, and how to support your patients with targeted, evidence-based care strategies.
You’ll also receive detailed clinical notes and curated research papers to deepen your understanding and help integrate nutrigenomic approaches into your practice.
Dr Lynch on the significance of MTHFR:
“I believe the MTHFR gene mutation is a major public health issue that remains widely overlooked. Millions are affected—through conditions like pulmonary embolisms, addictions, fibromyalgia, miscarriages, schizophrenia, severe depression, cancer, and autism."
"What connects these conditions? Often, a common thread is an MTHFR mutation. If we can prevent the activation of these mutations in utero, we could change the trajectory of health for generations."
"I’m committed to researching practical, effective ways to improve the health of people with MTHFR mutations—no matter how minor or severe. This work continues to evolve every week.”
If you want to stay at the forefront of personalised medicine and support your patients with truly targeted care, this course is a must.
